'Recirculating cardiac delivery' method of gene delivery should be called 'non-recirculating' method

Gene Therapy

Volumn 16, Issue 7, 2009, Pages 939-940

  Bridges, C R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARVOVIRUS VECTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; UNCLASSIFIED DRUG;

CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; DRUG MEGADOSE; GENE TARGETING; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CORONARY CIRCULATION; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART FAILURE; SHEEP;

EID: 67749097507     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.35     Document Type: Letter

References (4)

1. Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Therapy 2008; 15: 1550-1557.
2. Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R et al. Percutaneous cardiac recirculation-mediated gene transfer o of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007; 50: 253-260.
3. Bridges CR, Burkman JM, Malekan R, Konig SK, Chen H, Yarnall CB et al Global cardiac-specific transgene expression using cardio-pulmonary bypass with cardiac isolation. Ann Thorac Surg 2002; 73: 1939-1946.
4. Bridges CR, Gopal K, Holt DE, Yarnall C, Cole S, Anderson RB et al Efficient myocyte gene delivery using complete cardiac surgical isolation in situ. J Thorac Cardiovasc Surg 2005; 130: 1364-1370.